In early-stage life science and medtech companies, the issue is rarely a lack of substance. More often, it’s a lack of clarity in how that substance is communicated. I’ve seen rigorous thinking get lost in technical detail, promising data presented without clear interpretation, and founders struggling to share a coherent narrative.

My approach is simple: I listen first. I focus on how you reason, how you interpret your own data, and where the story becomes unclear to someone outside your field. From there, I help shape a narrative that reflects the science honestly while making it understandable to others.

My academic background includes a bachelors degree in economics (with minors in math and philosophy), and a masters degree in epidemiology from Tel Aviv University where my research focused on the relationship between naturalistic psychedelic use and co-occurring substance use disorders. I've also worked as a research assistant in the fields of economics and medical decision making. For the past 4 years, I've been working as a senior grant consultant helping life science companies communicate complex science clearly and effectively.

I like to say that my superpower is curiosity. It allows me to stay with complexity, ask better questions, and help founders see their work more clearly. I focus on scientific storytelling grounded in real understanding, structured with decision-making in mind. I’m not a regulatory consultant, a design agency, or a generic pitch deck service. My role is narrower and deeper: to help you present a scientific narrative that makes potential investors want to support your business.

I started this work because I've seen too many founders struggle with representing their scientific narrative to investors.